RP-phase quasi-two-dimensional perovskite thin films, their preparation methods, and perovskite solar cells

By introducing N-(2-hydroxyethyl)-N-methylformamide (HEMFA) as a crystallization regulator in the preparation of RP phase quasi-two-dimensional perovskite thin films, the problems of insufficient solvent coordination and poor stability of peroxide-based regulators were solved, achieving high vertical orientation and phase uniformity growth, breaking through the open-circuit voltage bottleneck, and improving the stability and efficiency of the device.

CN123124648APending Publication Date: 2026-11-17HEBEI UNIVERSITY
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202611387317.4
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2026-09-08
Publication Date
2026-11-17

AI Technical Summary

Technical Problem

In existing RP phase quasi-two-dimensional perovskite thin film preparation processes, insufficient solvent coordination leads to the formation of needle-like phases and vertical phase segregation. The poor stability of peroxide-based regulators results in limited open-circuit voltage of devices, making it difficult to meet industrialization requirements.

Method used

N-(2-hydroxyethyl)-N-methylformamide (HEMFA) was used as a crystallization regulator, and combined with a solvent-free hot spin coating process, the crystallization kinetics were precisely controlled through the strong synergistic chelation of the amide carbonyl group and the side chain hydroxyl group with Pb2+, inducing highly vertical orientation and phase homogeneous growth.

Benefits of technology

The through-hole needle phase was completely eliminated, improving the phase purity and crystallization uniformity of the thin film, achieving an open-circuit voltage of up to 1.2V, and improving the stability and reproducibility of the device.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN123124648A_ABST
    Figure CN123124648A_ABST
Patent Text Reader

Abstract

This invention belongs to the field of optoelectronic materials and solar cell fabrication technology, specifically relating to an RP-phase quasi-two-dimensional perovskite thin film, its preparation method, and a perovskite solar cell. The invention involves dissolving a quasi-two-dimensional perovskite precursor, methylamine chloride, and HEMFA in N,N-dimethylformamide to obtain a precursor solution; coating this solution onto a preheated substrate and annealing it to obtain the RP-phase quasi-two-dimensional perovskite thin film. By using HEMFA as a crystallization regulator in the quasi-two-dimensional perovskite precursor solution, the amide carbonyl group of HEMFA reacts with the side-chain hydroxyl group and Pb... 2+ The synergistic and strong chelation effect of the RP phase precisely controls the crystallization kinetics of the thin film, inducing the high vertical orientation and uniform growth of the quasi-two-dimensional perovskite. This aims to solve the technical problems in the existing hot spin coating process, such as the formation of needle-like phases and vertical phase segregation due to insufficient solvent coordination, as well as the poor stability of peroxide-based regulators and their tendency to introduce trap states, which limit the open-circuit voltage of the device.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention belongs to the field of optoelectronic materials and solar cell fabrication technology, specifically relating to an RP phase quasi-two-dimensional perovskite thin film, its preparation method, and a perovskite solar cell. Background Technology

[0002] RP (Ruddlesden-Popper) phase quasi-two-dimensional perovskite materials are a class of organic-inorganic hybrid semiconductor materials with a natural quantum well structure, and their general formula is (LA)2(A). n−1 Pb n X n+1 LA is a long-chain alkylammonium cation (such as BA). + Butylamine ion, PEA + (e.g., phenylethylamine ion), A is a small cation (e.g., MA). + Methylamine ion, FA + (Formamidinium ion, etc.), X is a halide anion, and n represents the number of inorganic octahedral layers, where n is an integer. Compared to three-dimensional perovskites, RP-phase quasi-two-dimensional perovskites separate the inorganic octahedral framework at the atomic scale through organic isolation layers, forming strong quantum confinement and dielectric confinement effects. This not only increases exciton binding energy and extends carrier lifetime but also significantly improves the environmental stability of the material, making it highly promising for applications in high-efficiency and stable photovoltaic devices and perovskite solar cells (PSCs).

[0003] In the solution-based preparation of RP-phase quasi-two-dimensional perovskites, precise control of crystallization kinetics directly determines the final morphology, phase distribution, and photoelectric properties of the film. Traditional preparation processes mostly rely on anti-solvent methods (such as using poor solvents like chlorobenzene and diethyl ether) to trigger supersaturated nucleation. However, this method has an extremely narrow operating window (highly sensitive to drop time, volume, and gas flow rate), poor process reproducibility, and is difficult to adapt to the industrial-scale preparation requirements of large-area coating.

[0004] However, when using the simpler, more scalable spin-coating method, without introducing any crystallization regulators, the conventional N,N-dimethylformamide (DMF) solvent has weak coordination with lead iodide (PbI2), failing to effectively delay the polymerization and crystallization process of the PbI2 framework in the precursor solution. This easily leads to the formation of disordered, through-type needle-like phases inside and even on the surface of the film; simultaneously, small-sized cations (such as MA) + With low crystallization barriers and fast diffusion rates, it is extremely easy for 3D perovskite phases to precipitate disorderedly within the film in advance, forcing the large-size isolation of cations (such as BA) to be isolated. +The phases accumulate at the bottom of the thin film, causing severe vertical phase segregation. The aforementioned uneven phase distribution and needle-like phase defects not only damage the compactness of the thin film, but also form a large number of non-radiative recombination centers and leakage channels that penetrate the device, which greatly limits the improvement of the open-circuit voltage of quasi-two-dimensional perovskite solar cells (the open-circuit voltage of conventional pure DMF thermal spin coating systems is usually difficult to exceed 1.15V).

[0005] In addition, although existing reports of peroxide-based solvent-derived regulators (such as dimethyl sulfoxide-DMSO derivatives) can improve coordination ability to delay the crystallization rate of PbI2, these compounds containing peroxide bonds (-OO-) have poor chemical stability and are prone to decomposition at room temperature to produce destructive impurities such as formic acid and formaldehyde. This results in poor precursor storage stability, poor batch repeatability of devices, and residues inside the thin film during annealing, forming deep-level trap states, which degrades the open-circuit voltage of the device and makes it difficult to meet the requirements of practical applications. Summary of the Invention

[0006] This invention provides a highly vertically oriented RP phase quasi-two-dimensional perovskite thin film based on N-(2-hydroxyethyl)-N-methylformamide, its preparation method, and a perovskite solar cell. This invention utilizes N-(2-hydroxyethyl)-N-methylformamide as a crystallization regulator, combined with a solvent-free thermal spin coating process, to induce highly vertically oriented and homogeneous growth of the RP phase quasi-two-dimensional perovskite. It aims to solve the technical problems in existing thermal spin coating processes where insufficient solvent coordination leads to needle-like phase formation and vertical phase segregation, as well as the poor stability of peroxide-based regulators and their tendency to introduce trapped states, resulting in limited open-circuit voltage of the device.

[0007] To achieve the above objectives, the technical solution of the present invention is as follows.

[0008] The first aspect of this invention provides a method for preparing RP-phase quasi-two-dimensional perovskite thin films, comprising the following steps: A quasi-two-dimensional perovskite precursor, methylamine chloride, and N-(2-hydroxyethyl)-N-methylformamide were dissolved in N,N-dimethylformamide to obtain a precursor solution. The precursor solution was coated onto a preheated substrate and annealed to obtain a vertically oriented RP-phase quasi-two-dimensional perovskite film. The amount of N-(2-hydroxyethyl)-N-methylformamide added was 0.5% to 20% of the molar amount of lead source in the quasi-two-dimensional perovskite precursor.

[0009] This invention uses N-(2-hydroxyethyl)-N-methylformamide (HEMFA, molecular formula C4H9NO2, structural formula: O=CH-N(CH3)-CH2CH2-OH) as a crystallization regulator. By introducing HEMFA into a quasi-two-dimensional perovskite precursor solution, it utilizes the interaction between its amide carbonyl group and side-chain hydroxyl groups and Pb... 2+The synergistic and strong chelating effect of HEMFA precisely regulates the crystallization kinetics of the thin film. During film formation, HEMFA successfully induced crystal growth with a highly vertical orientation from top to bottom, reversing the system's dependence on BA. + and MA + The binding force of ions. The method of this invention completely eliminates the through-type needle-like phase that easily occurs in traditional preparation processes, significantly improving the phase purity and crystallinity uniformity of quasi-two-dimensional perovskite films. The highly vertically oriented, high-phase-purity RP-phase quasi-two-dimensional perovskite films prepared based on this method can be used to fabricate quasi-two-dimensional perovskite solar cells, effectively suppressing non-radiative recombination and leakage current, achieving an open-circuit voltage as high as 1.2V, and providing a novel preparation strategy for efficient and stable quasi-two-dimensional perovskite optoelectronic devices.

[0010] Preferably, the amount of N-(2-hydroxyethyl)-N-methylformamide added is 2% to 10% of the molar amount of lead source in the quasi-two-dimensional perovskite precursor. This molar ratio range maximizes the crystallization control effect of N-(2-hydroxyethyl)-N-methylformamide (HEMFA) while avoiding excessive additive residue from damaging the perovskite lattice and introducing device defects. More preferably, the amount of N-(2-hydroxyethyl)-N-methylformamide added is 5% of the molar amount of lead source in the quasi-two-dimensional perovskite precursor.

[0011] The HEMFA of this invention can completely eliminate the needle-like phase that is easily generated in the PbI2 and conventional DMF system through the dual regulation of chelation-controlled crystallization kinetics and selective binding of cations, thus significantly improving the uniformity and compactness of the internal crystalline phase of the film.

[0012] Preferably, the amount of methylammonium chloride added is 12% to 15% of the molar amount of lead source in the quasi-two-dimensional perovskite precursor.

[0013] Preferably, the quasi-two-dimensional perovskite precursor is obtained by mixing a lead source, a butylammonium ion source, and a methylammonium ion source; the molar ratio of the lead source, the butylammonium ion source, and the methylammonium ion source is n:2:n-1; where n is an integer; more preferably, n=4, 5, or 6. HEMFA reacts with methylammonium ions (MA) in the precursor solution. + It has strong hydrogen bonding ability, and this binding effect can delay MA + The coordination crystallization rate with the lead halide framework is reduced, thereby suppressing the premature precipitation of disordered 3D perovskite phases and optimizing the phase distribution uniformity in the vertical direction of the film.

[0014] Preferably, the preheating temperature of the substrate is 60℃~70℃.

[0015] Preferably, the annealing temperature is 100℃~110℃ and the annealing time is 10min~15min.

[0016] Preferably, the coating rotation speed is 4500 rpm to 5000 rpm. This invention employs a one-step thermal spin coating process without the aid of anti-solvents.

[0017] Preferably, the substrate is a substrate with a hole transport layer deposited on it.

[0018] A second aspect of the present invention provides an RP-phase quasi-two-dimensional perovskite thin film, which is prepared by the aforementioned method for preparing RP-phase quasi-two-dimensional perovskite thin films.

[0019] Preferably, the RP phase quasi-two-dimensional perovskite film uses N-(2-hydroxyethyl)-N-methylformamide as a crystallization regulator, utilizing the crystallization regulator to react with Pb in the quasi-two-dimensional perovskite precursor. 2+ A bidentate chelate complex is formed to induce the ordered, top-to-bottom stacking growth of the inorganic perovskite lattice and the organic cations in the quasi-two-dimensional perovskite precursor in a direction perpendicular to the substrate, forming a vertically oriented RP-phase quasi-two-dimensional perovskite thin film; the inorganic perovskite lattice is PbI6. 4- An inorganic framework layer formed by octahedrons interconnected through shared vertices; the organic cation is butylammonium ion (BA). + ) and methylammonium ion (MA + ).

[0020] During the spin coating and annealing process, N-(2-hydroxyethyl)-N-methylformamide (HEMFA) can react with Pb through the synergistic effect of the amide carbonyl group and the side chain hydroxyl group. 2+ A stable chelate structure is formed, and its binding strength is significantly higher than that of conventional DMF and Pb. 2+ The monodentate coordination effect; conventional DMF with a lower boiling point preferentially evaporates and desorbs from the liquid film, and then HEMFA-Pb is enriched on the film surface. 2+ Chelates can guide the growth of quasi-two-dimensional crystals from top to bottom with high vertical orientation and high uniformity.

[0021] A third aspect of this invention provides a perovskite solar cell, comprising a light-absorbing layer, wherein the light-absorbing layer is the RP-phase quasi-two-dimensional perovskite thin film described in the second aspect. Thanks to the complete elimination of the needle-like phase and the improved phase purity resulting from high vertical orientation, the non-radiative recombination and leakage current channels of this solar cell device are significantly suppressed, and the open-circuit voltage can stably reach 1.2V or higher.

[0022] Preferably, the perovskite solar cell comprises ITO conductive glass and NiO. x The composition consists of a bottom layer, a composite hole transport layer, an RP-phase quasi-two-dimensional perovskite thin film, an electron transport layer, an interface modification layer, and a top electrode.

[0023] ITO conductive glass is made by combining a glass substrate and an ITO conductive layer; specifically, ITO conductive glass has an ITO conductive layer with a thickness of 130nm to 150nm formed on the surface of the glass substrate. NiO x The thickness of the nickel oxide (NiO) substrate is 10 nm–15 nm. The thickness of the composite hole transport layer is 1 nm–2 nm. The thickness of the RP phase quasi-two-dimensional perovskite film is 350 nm–450 nm. The thickness of the electron transport layer is 20 nm–30 nm. The thickness of the interface modification layer is 6 nm–8 nm. The thickness of the top electrode is 100 nm.

[0024] The composite hole transport layer is made of MEO-2PACz (Chinese name: (2-(3,6-dimethoxy-9H-carbazole-9-yl)ethyl)phosphonic acid); the electron transport layer is made of PCBM (Chinese name: (6,6)-phenyl-C61-butyric acid methyl ester); the interface modification layer is made of BCP (bathing copper spirit, chemical name: 2,9-dimethyl-4,7-diphenyl-1,10-phenanthroline); and the top electrode is made of Ag.

[0025] The beneficial effects of this invention are: 1. This invention introduces N-(2-hydroxyethyl)-N-methylformamide (HEMFA) as a crystallization regulator into a quasi-two-dimensional perovskite precursor solution, utilizing the amide carbonyl group of HEMFA and the side-chain hydroxyl group and Pb 2+ The synergistic and strong chelating effect of HEMFA precisely regulates the crystallization kinetics of the thin film. During film formation, HEMFA successfully induced crystal growth with a highly vertical orientation from top to bottom, reversing the effect of the system on BA. + and MA + The binding force of ions completely eliminates the through-type needle-like phase that is prone to occur in traditional preparation processes, and significantly improves the phase purity and crystallization uniformity of quasi-two-dimensional perovskite films.

[0026] 2. The highly vertically oriented and high-phase-purity RP-phase quasi-two-dimensional perovskite thin film prepared by the method of the present invention can be used to prepare quasi-two-dimensional perovskite solar cells, effectively suppressing non-radiative recombination and leakage current, and achieving an open-circuit voltage of up to 1.2V, providing a new preparation strategy for efficient and stable quasi-two-dimensional perovskite optoelectronic devices.

[0027] 3. The process of this invention is simple and highly reproducible. It completely eliminates the antisolvent drop-addition process, which has a narrow operating window and is difficult to scale up for industrial application. Film can be formed simply by introducing a quantitative crystallization regulator into the precursor and combining it with conventional hot spin coating. Furthermore, HEMFA has stable chemical properties, no risk of peroxy bond decomposition, long shelf life of the precursor solution, and small batch-to-batch differences in devices, which greatly broadens the process window and application feasibility.

[0028] 4. The purity and uniformity of the thin film phase of the present invention are significantly improved. Relying on the dual regulation effect of HEMFA, the fatal segregation phenomenon of penetrating needle-like phase and vertical phase in the traditional hot spin coating process is completely eliminated, and each n-value phase is highly uniformly distributed throughout the entire film.

[0029] 5. This invention overcomes the open-circuit voltage bottleneck and improves stability. Thanks to the highly uniform phase distribution of the thin film, the highly vertically oriented crystal structure, and the complete elimination of leakage channels such as needle-like phases and pores, the quasi-two-dimensional perovskite solar cells prepared based on this technology exhibit excellent photoelectric performance, and the open-circuit voltage can stably exceed 1.2V, reaching an advanced level in the field; at the same time, no decomposition impurities are introduced into the regulator, significantly improving the long-term operational stability of the device. Attached Figure Description

[0030] Figure 1 The proton nuclear magnetic resonance spectra of pure DMF, pure HEMFA, and DMF-PbI2, HEMFA-PbI2, DMF-BAI, HEMFA-BAI, DMF-MAI, and HEMFA-MAI ( 1 H NMR comparison diagram. Among them, (a) shows the difference between pure DMF and DMF-PbI2. 1 (a) 1H NMR spectrum; (b) shows pure HEMFA and HEMFA-PbI2. 1 H NMR spectrum; (c) shows DMF-BAI and HEMFA-BAI. 1 H NMR spectra; (d) shows DMF-MAI and HEMFA-MAI. 1 H NMR spectrum.

[0031] Figure 2 These are comparative images of the in-situ heating microscopy crystallization process at 50°C for the Example (HEMFA optimal addition control system) and the Comparative Example (pure DMF system). Specifically, (a) is the in-situ heating microscopy crystallization image of the Comparative Example (pure DMF system); (b) is the in-situ heating microscopy crystallization image of the Example (1% HEMFA system); (c) is the in-situ heating microscopy crystallization image of the Example (3% HEMFA system); (d) is the in-situ heating microscopy crystallization image of the Example (5% HEMFA system); (e) is the in-situ heating microscopy crystallization image of the Example (10% HEMFA system); and (f) is the in-situ heating microscopy crystallization image of the Example (15% HEMFA system).

[0032] Figure 3The images show a comparison of the surface morphology and cross-sectional scanning electron microscope (SEM) images of the quasi-two-dimensional perovskite films prepared in the examples (HEMFA-controlled system) and the comparative example (pure DMF system). Specifically, (a) shows the surface morphology of the quasi-two-dimensional perovskite film prepared in the examples; (a1) shows the SEM cross-sectional image of the quasi-two-dimensional perovskite film prepared in the examples; (b) shows the surface morphology of the quasi-two-dimensional perovskite film prepared in the comparative example; and (b1) shows the SEM cross-sectional image of the quasi-two-dimensional perovskite film prepared in the comparative example.

[0033] Figure 4 X-ray diffraction patterns and UV-Vis absorption spectra of quasi-two-dimensional perovskite films prepared for the examples (HEMFA-controlled system) and the comparative example (pure DMF system). (a) is the X-ray diffraction pattern; (b) is the UV-Vis absorption spectrum.

[0034] Figure 5 Two-dimensional grazing-incidence X-ray wide-angle scattering (GIS) spectra of quasi-two-dimensional perovskite films prepared in the examples (HEMFA-controlled system) and the comparative example (pure DMF system). Specifically, (a) is the GIS spectra of the quasi-two-dimensional perovskite film prepared in the examples; and (b) is the GIS spectra of the quasi-two-dimensional perovskite film prepared in the comparative example.

[0035] Figure 6 The images show photoluminescence scanning images of the quasi-two-dimensional perovskite thin films prepared in the examples and comparative examples. Specifically, (a) is a photoluminescence scanning image of the quasi-two-dimensional perovskite thin film prepared in the examples; and (b) is a photoluminescence scanning image of the quasi-two-dimensional perovskite thin film prepared in the comparative examples.

[0036] Figure 7 The images show the external quantum efficiency and electroluminescence spectra of the quasi-two-dimensional perovskite solar cell devices prepared in the examples and comparative examples. (a) shows a comparison of external quantum efficiency; (b) shows a comparison of electroluminescence spectra.

[0037] Figure 8 This is a comparison of the current density-voltage characteristic curves of quasi-two-dimensional perovskite solar cells prepared based on the examples and comparative examples. Detailed Implementation

[0038] To make the objectives, technical solutions, and advantages of this invention clearer, the invention will be further described in detail below with reference to embodiments. It should be understood that the specific embodiments described herein are merely illustrative and not intended to limit the invention. All other embodiments obtained by those skilled in the art based on the embodiments of this invention without inventive effort are within the scope of protection of this invention.

[0039] It should be noted that all numerical ranges involved in this invention (such as the amount of HEMFA added, synthesis reaction temperature and time, film annealing temperature, spin coating speed, etc.) cover the two endpoints of the range and any specific value between the two endpoints. Those skilled in the art can flexibly select suitable parameters within the corresponding range based on the crystallization control logic disclosed in this invention. The above embodiments are merely preferred embodiments of this invention, used to exemplarily illustrate the technical solution and implementation effects of this invention. Without departing from the core inventive concept of this invention, those skilled in the art can make various equivalent substitutions, adjustments, modifications, or optimizations to the synthesis process parameters of the HEMFA crystallization regulator, the composition ratio of the quasi-two-dimensional perovskite precursor, the stacked structure of the device, and the preparation process; all such modifications made based on the technical essence of this invention should fall within the scope of protection of the claims of this invention.

[0040] The technical solution of the present invention will be further described below through specific embodiments. In the following embodiments, unless otherwise specified, the methods are conventional methods; the reagents and materials, unless otherwise specified, are commercially available. BAI represents butylammonium iodide; MAI represents methylammonium iodide; the chemical formula of lead iodide is PbI2.

[0041] This invention mainly introduces chemically stable N-(2-hydroxyethyl)-N-methylformamide (HEMFA) as a crystallization regulator. While maintaining good compatibility between the formamide core and the precursor system, additional coordination sites are introduced through the side chain hydroxyl groups to achieve precise control of perovskite crystallization kinetics.

[0042] N-(2-hydroxyethyl)-N-methylformamide (HEMFA) is prepared by a one-step azeotropic dehydration amidation reaction, and the specific preparation method is as follows: To a 250 mL three-necked flask equipped with a spherical water separator, a reflux condenser, and a magnetic stirrer, add 0.5 mol of redistilled purified N-methylethanolamine and 0.6 mol of anhydrous formic acid, along with 80 mL of dried toluene as an azeotropic dehydrating agent. Place the flask in a standard oil bath, turn on the magnetic stirrer, and slowly heat to an internal temperature of 125℃–130℃. Maintain reflux for 6 hours to separate the water layer. Stop heating and terminate the reaction when the volume of the water layer in the water separator no longer increases. After cooling the reaction solution to room temperature, transfer it to a rotary evaporator and remove toluene and excess formic acid by rotary evaporation at atmospheric pressure. Subsequently, connect a circulating water vacuum pump for distillation, collecting the fraction from 118℃ / 2 kPa to 120℃ / 2 kPa, finally obtaining a colorless and transparent liquid product (HEMFA) with a purity ≥95%. Figure 1 (b) 11H NMR characterization confirmed that the HEMFA product under these conditions exhibited excellent selectivity, with no side reactions such as hydroxyl esterification and amide decomposition, and no residual harmful perovskite impurities such as halide ions and metal ions.

[0043] The molecular structure of HEMFA in this invention retains the formamide coordination core of DMF, while introducing terminal hydroxyl groups into the N-atom side chain to form a dual-coordination site structure of amide carbonyl group and side chain hydroxyl group, which can react with Pb. 2+ A stable chelation reaction is formed, with coordination strength significantly higher than that of pure DMF's monodentate coordination. By precisely controlling the amount of HEMFA added, this invention can achieve highly vertically oriented and highly phase-uniform growth of quasi-two-dimensional perovskite films without introducing antisolvents, while avoiding the introduction of impurities through the decomposition of the regulator, and significantly improving the storage stability of the precursor and the batch repeatability of the device.

[0044] In the process of hot spin coating and subsequent annealing without anti-solvent assistance, the HEMFA of this invention achieves precise control over the film crystallization process through a dual mechanism of phase distribution regulation by binding force and vertical orientation induction by surface anchoring. The mechanism is as follows:

[0045] 1. Binding force reversal and phase homogenization (suppression of 3D phase and harmful needle-like phase): In traditional pure DMF systems, due to the small size of cations (such as MA) + The crystallization barrier is extremely low and the diffusion is extremely fast, making it very easy to combine with PbI6. 4- The preferential and disordered binding of the octahedral framework leads to the precipitation of a large amount of uncontrolled 3D perovskite phase inside the film; at the same time, the conventional reaction between DMF and lead iodide readily generates harmful penetrating one-dimensional needle-like phases (MA2Pb3I8-DMF) explosively on the film surface, consuming a large amount of MA. + This, in turn, forces the isolation of large-size cations (such as BA) + The high n-value phase is stacked between the high n-value phase and the 3D phase to form a randomly oriented insulating low n-value phase (n≤2).

[0046] The introduction of HEMFA in this invention reshapes the thermodynamic and kinetic equilibrium of the system's crystallization. On one hand, the amide carbonyl group and side-chain hydroxyl group of the HEMFA molecule can synergistically react with Pb²⁻. + The formation of a bidentate chelate structure results in a binding strength far exceeding that of the monodentate coordination of conventional DMF, effectively delaying the dissociation and nucleation rate of lead halide complexes. Furthermore, the oxygen-containing sites of HEMFA can form hydrogen bonds with ammonium cations, and their binding ability to cations of different sizes varies significantly: small-sized MA... + With low steric hindrance, it can simultaneously approach carbonyl and hydroxyl sites, forming multiple strong hydrogen bonds with significant binding effect; while large-sized BA with long alkyl chains +The large steric hindrance makes it difficult to approach the polar side chains and form effective bonds, resulting in a weak binding effect. This is true for MA + Strong integration ability, for BA + The weak bonding force reversal effect increases MA. + The activation energy of the embedded perovskite lattice slows down the coordination crystallization rate with the lead halide framework, thereby inhibiting the premature precipitation of disordered 3D phases and eliminating the nucleation space of needle-like mesophases. This makes the crystallization process smooth and controllable, and ultimately achieves a highly uniform distribution of each n-value phase throughout the entire film.

[0047] 2. Inducing top-down, highly vertical orientation growth (lattice anchoring effect): During the high-temperature evaporation stage of thermal spin coating, due to the significant difference between solvent boiling points and coordination binding energies, the system exhibits a distinct gradient evaporation effect: conventional DMF has a lower boiling point (approximately 153°C) and weaker coordination ability, preferentially desorbing and evaporating rapidly from the liquid film; while HEMFA has a much higher boiling point than DMF (approximately 220°C) and reacts with Pb... 2+ Due to strong chelation and a significantly slower evaporation rate, HEMFA-Pb gradually accumulates at the liquid-gas interface (surface layer) of the film as the solvent evaporates during spin coating. 2+ The chelated complex acts as a stable anchoring template along the crystal growth direction. As the subsequent annealing process proceeds, this surface template guides the subsequent formation of the inorganic perovskite lattice and organic cations (BACs). + with MA + The film is grown in an ordered, top-down stacked manner perpendicular to the substrate, ultimately forming a highly vertically oriented thin film morphology. This top-down growth mechanism not only opens up the charge transport channels in the vertical direction of the device and eliminates the obstruction of carrier transport by the insulating organic layer parallel to the substrate, but also forms a dense, pore-free, high-quality microstructure, significantly reducing the defect density of the thin film.

[0048] Example 1 A method for preparing an RP-phase quasi-two-dimensional perovskite thin film includes the following steps: S1. Preparation of precursor solution: according to (BA)2(MA) n-1 Pb n I n+1 (n=4) stoichiometric ratios of butylammonium iodide (BAI), methylammonium iodide (MAI), and lead iodide (PbI2) were weighed out. 15% of the molar amount of PbI2 was added as an additive, and the mixture was dissolved in 1 mL of DMF main solvent (according to a lead iodide concentration of 1 mol / L). At the same time, 1% of the molar amount of PbI2 was added, and the mixture was stirred at room temperature for 1 h until completely clear. The solution was then filtered through a 0.22 μm organic filter membrane to obtain the precursor solution.

[0049] S2. Solvent-free hot spin coating: The substrate with the deposited transport layer is preheated to 70°C. The precursor solution is dropped onto the hot substrate and spin-coated at 5000 rpm for 40 seconds without adding any anti-solvent. After spin coating, the substrate is immediately transferred to a 110°C hot stage for annealing for 10 minutes to obtain an RP phase quasi-two-dimensional perovskite film.

[0050] In Example 1, the amount of HEMFA added was 1% of the molar amount of PbI2. Verification of crystallization control of the precursor solution in Example 1: A clean glass slide was placed on a precision hot stage and preheated to 50°C. 5 μL of the precursor solution was dropped onto the surface of the hot glass slide. In-situ crystallization observation under a microscope showed that in Example 1, the crystallization induction time was slightly longer than that of the pure DMF system, with crystallization beginning at 240 s. Some scattered needle-like intermediate phases still existed. The uniformity of the thin film phase was improved, but not to the optimal level.

[0051] Example 2 A method for preparing an RP-phase quasi-two-dimensional perovskite thin film differs from Example 1 in that the amount of HEMFA added is 3% of the molar amount of PbI2. The specific preparation method includes the following steps:

[0052] S1. Preparation of precursor solution: according to (BA)2(MA) n-1 Pb n I n+1 BAI, MAI and PbI2 were weighed in a stoichiometric ratio of (n=4). 15% of the molar amount of PbI2 was added as an additive, and the mixture was dissolved in 1 mL of DMF main solvent (prepared according to a concentration of 1 mol / L of lead iodide). At the same time, 3% of the molar amount of PbI2 was added, and the mixture was stirred at room temperature for 1 h until it was completely clear. The solution was then filtered through a 0.22 μm organic filter membrane to obtain the precursor solution.

[0053] S2. Solvent-free hot spin coating: The substrate with the deposited transport layer is preheated to 70°C. The precursor solution is dropped onto the hot substrate and spin-coated at 5000 rpm for 40 seconds without adding any anti-solvent. After spin coating, the substrate is immediately transferred to a 110°C hot stage for annealing for 10 minutes to obtain an RP phase quasi-two-dimensional perovskite film.

[0054] Verification of crystallization control of the precursor solution in Example 2: A clean glass slide was placed on a precision hot stage and preheated to 50°C. 5 μL of the precursor solution was dropped onto the surface of the hot glass slide. After in-situ crystallization observation under a microscope, in Example 2, the crystallization induction time was further extended, and crystallization began at 290 s. Only a very small amount of short needle-like intermediate phase remained. The uniformity of the thin film phase was slightly improved, and the vertical orientation of the grains was significantly enhanced.

[0055] Example 3 A method for preparing RP-phase quasi-two-dimensional perovskite thin films differs from Example 1 in that the amount of HEMFA added is 5% of the molar amount of PbI2. The specific preparation method includes the following steps:

[0056] S1. Preparation of precursor solution: according to (BA)2(MA) n-1 Pb n I n+1 BAI, MAI and PbI2 were weighed in a stoichiometric ratio of (n=4). 15% of the molar amount of PbI2 was added as an additive, and the mixture was dissolved in 1 mL of DMF main solvent (according to a concentration of 1 mol / L of lead iodide). At the same time, 5% of the molar amount of PbI2 was added, and the mixture was stirred at room temperature for 1 h until it was completely clear. The precursor solution was obtained by filtration through a 0.22 μm organic filter membrane.

[0057] S2. Solvent-free hot spin coating: The substrate with the deposited transport layer is preheated to 70°C. The precursor solution is dropped onto the hot substrate and spin-coated at 5000 rpm for 40 seconds without adding any anti-solvent. After spin coating, the substrate is immediately transferred to a 110°C hot stage for annealing for 10 minutes to obtain an RP phase quasi-two-dimensional perovskite film.

[0058] Verification of crystallization control of the precursor solution in Example 3: A clean glass slide was placed on a precision hot stage and preheated to 50°C. 5 μL of the precursor solution was dropped onto the surface of the hot glass slide. After in-situ crystallization observation under a microscope, in Example 3, the crystallization induction time was further extended, and crystallization began at 350 s. No needle-like mesophase precipitated throughout the process, and there was no explosive nucleation. The uniformity and vertical orientation of the thin film phase both reached the optimal level.

[0059] Example 4 A method for preparing an RP-phase quasi-two-dimensional perovskite thin film differs from Example 1 in that the amount of HEMFA added is 10% of the molar amount of PbI2. The specific preparation method includes the following steps:

[0060] S1. Preparation of precursor solution: according to (BA)2(MA) n-1 Pb n I n+1 BAI, MAI and PbI2 were weighed in a stoichiometric ratio of (n=4). 15% of the molar amount of PbI2 was added as an additive, and the mixture was dissolved in 1 mL of DMF main solvent (according to a concentration of 1 mol / L of lead iodide). At the same time, 10% of the molar amount of PbI2 was added, and the mixture was stirred at room temperature for 1 h until it was completely clear. The precursor solution was obtained by filtration through a 0.22 μm organic filter membrane.

[0061] S2. Solvent-free hot spin coating: The substrate with the deposited transport layer is preheated to 70°C. The precursor solution is dropped onto the hot substrate and spin-coated at 5000 rpm for 40 seconds without adding any anti-solvent. After spin coating, the substrate is immediately transferred to a 110°C hot stage for annealing for 10 minutes to obtain an RP phase quasi-two-dimensional perovskite film.

[0062] Verification of crystallization control of the precursor solution in Example 4: A clean glass slide was placed on a precision hot stage and preheated to 50°C. 5 μL of the precursor solution was dropped onto the surface of the hot glass slide. After in-situ crystallization observation under a microscope, in Example 4, the crystallization induction time was significantly prolonged, crystallization began at 420 s, and the crystallization rate slowed down. There were no needle-like mesophases throughout the process, the grain size was slightly differentiated, and the uniformity of the thin film phase was slightly lower than that of the optimal group.

[0063] Example 5 A method for preparing RP-phase quasi-two-dimensional perovskite thin films differs from Example 1 in that the amount of HEMFA added is 15% of the molar amount of PbI2. The specific preparation method includes the following steps:

[0064] S1. Preparation of precursor solution: according to (BA)2(MA) n-1 Pb n I n+1 BAI, MAI, and PbI2 were weighed in a stoichiometric ratio of (n=4). 15% of the molar amount of PbI2, containing MACl as an additive, was added and dissolved in 1 mL of DMF as the main solvent (prepared according to a lead iodide concentration of 1 mol / L). Simultaneously, 15% of the molar amount of PbI2, containing HEMFA, was added. The mixture was stirred at room temperature for 1 h until completely clear. The solution was then filtered through a 0.22 μm organic filter membrane to obtain the precursor solution. S2. Solvent-free spin coating: The substrate with the deposited transport layer was preheated to 70°C. The precursor solution was drop-coated onto the hot substrate and spin-coated at 5000 rpm for 40 s without adding any anti-solvent. Immediately after spin-coating, the substrate was transferred to a 110°C hot plate for annealing for 10 min to obtain a quasi-two-dimensional perovskite film.

[0065] Verification of crystallization control of the precursor solution in Example 5: A clean glass slide was placed on a precision hot stage and preheated to 50°C. 5 μL of the precursor solution was dropped onto the surface of the hot glass slide. In situ crystallization observation under a microscope showed that in Example 5, the crystallization induction time was significantly prolonged, and crystallization began at 470 s. The crystal growth rate was significantly slower. There were still no needle-like mesophases throughout the process, but the grain morphology was irregular and local agglomeration occurred. The film density decreased and the phase homogeneity was further reduced.

[0066] Comparative Example 1 A method for preparing RP-phase quasi-two-dimensional perovskite thin films differs from Example 1 in that no HEMFA is added to the precursor solution; pure DMF is used entirely as the solvent. The remaining preparation processes and parameters are completely identical. The specific preparation method includes the following steps:

[0067] S1. Preparation of precursor solution: according to (BA)2(MA) n-1 Pb n I n+1 BAI, MAI and PbI2 were weighed in stoichiometric ratio (n=4), and MACl was added as an additive at 15% of the molar amount of PbI2. The mixture was dissolved in 1 mL of DMF main solvent (according to the concentration of lead iodide at 1 mol / L). The mixture was stirred at room temperature for 1 h until completely clear, and then filtered through a 0.22 μm organic filter membrane to obtain the precursor solution.

[0068] S2. Solvent-free hot spin coating: The substrate with the deposited transport layer is preheated to 70°C. The precursor solution is dropped onto the hot substrate and spin-coated at 5000 rpm for 40 seconds without adding any anti-solvent. After spin coating, the substrate is immediately transferred to a 110°C hot stage for annealing for 10 minutes to obtain an RP phase quasi-two-dimensional perovskite film.

[0069] Verification of crystallization control of the precursor solution in Comparative Example 1: A clean glass slide was placed on a precision hot stage and preheated to 50°C. 5 μL of the precursor solution was dropped onto the surface of the hot glass slide. After in-situ crystallization observation under a microscope, it was found that in Comparative Example 1, the crystallization induction time was short and the crystallization rate was extremely fast. Crystallization began at 180 s, and a large number of disordered needle-like phases and scattered 3D island phases were precipitated explosively in the early stage. The vertical phase segregation of the thin film was severe, and the morphological uniformity was extremely poor.

[0070] Application Example 1 The fabrication method of quasi-two-dimensional perovskite solar cell devices is as follows: Substrate cleaning and hole transport layer preparation: ITO conductive glass was ultrasonically cleaned sequentially with deionized water, acetone, and anhydrous ethanol for 15 min each, dried with nitrogen, and then treated in a UV-ozone cleaner for 30 min. Subsequently, NiO was spin-coated onto the ITO glass surface (4000 rpm, 30 s). x The dispersion (15 mg / mL, deionized water) was annealed at 120 °C for 20 min to obtain NiO. x The bottom layer; next, a 0.2 mg / mL solution of 4-(3,6-dimethoxy-9H-carbazole-9-yl)butylphosphonic acid (MEO-4PACz) in anhydrous ethanol was spin-coated onto NiO at 4000 rpm. x The surface of the bottom layer was annealed at 100°C for 10 minutes to complete the ITO / NiO process. xPreparation of the / MEO-2PACz composite hole transport layer.

[0071] Precursor solution preparation: according to RP phase quasi-two-dimensional perovskite (BA)2 (MA) n-1 Pb n I 3n+1 With a stoichiometric ratio of n=4, butylammonium iodide (BAI), methylammonium iodide (MAI), lead iodide (PbI2) and MACl (15% of the molar amount of PbI2) were dissolved in 1 mL of DMF main solvent (according to the concentration of lead iodide at 1 mol / L). At the same time, HEMFA crystallization regulator (1% of the molar amount of PbI2) was added. After stirring at room temperature for 1 h, the mixture was filtered to obtain a clear perovskite precursor solution.

[0072] Solvent-free spin coating for perovskite layer preparation: The substrate with a hole transport layer deposited was preheated to 70°C. 30 μL of the perovskite precursor solution was rapidly drop-coated onto the hot substrate using a pipette, and immediately spin-coated at 5000 rpm for 40 s (without adding any anti-solvent). It was then quickly transferred to a 110°C hot plate for annealing for 10 min. Thanks to the bidentate chelation regulation and surface anchoring induction effect of HEMFA, a dense, needle-free, highly vertically oriented, and highly homogeneous RP-phase quasi-two-dimensional perovskite film was obtained.

[0073] Electron transport layer and top electrode fabrication: A PCBM chlorobenzene solution (20 mg / mL) was spin-coated at 1500 rpm onto the top of the RP-phase quasi-two-dimensional perovskite film as an electron transport layer; subsequently, a BCP isopropanol solution (0.5 mg / mL) was spin-coated at 4000 rpm as an interface modification layer. Finally, a 5 × 10⁻⁶ layer was applied. -4 Under high vacuum conditions of Pa, a 100 nm thick Ag electrode was thermally deposited to complete the assembly of a quasi-two-dimensional perovskite solar cell device.

[0074] Performance testing: The quasi-two-dimensional perovskite solar cell device of Application Example 1 was tested under AM 1.5G standard simulated sunlight using a photovoltaic performance tester.

[0075] The formula for calculating photoelectric conversion efficiency is: ;in, PCE Photoelectric conversion efficiency; V oc This is the open-circuit voltage; J sc This represents the short-circuit current density. FF The fill factor; P in The incident light power density is denoted as .

[0076] The results show that the photoelectric conversion efficiency of the quasi-two-dimensional perovskite solar cell device ( PCE The open-circuit voltage was 18.21%. V oc The voltage is 1.133V, and the short-circuit current density is ( J sc The value is 20.42 mA / cm. 2 Fill factor ( FF The figure was 78.7%.

[0077] Application Example 2 The fabrication method of the quasi-two-dimensional perovskite solar cell device in Application Example 1 was followed, except that the amount of HEMFA added to the precursor solution was 3% of the molar amount of PbI2.

[0078] Performance Testing: The device was tested using a photovoltaic performance tester under AM 1.5G standard simulated sunlight. The results show that the device… PCE It was 18.7%. V oc It is 1.17V. J sc 20.48 mA / cm 2 , FF It is 77.95%.

[0079] Application Example 3 The fabrication method of the quasi-two-dimensional perovskite solar cell device in Application Example 1 was followed, except that the amount of HEMFA added to the precursor solution was 5% of the molar amount of PbI2.

[0080] Performance Testing: The device was tested using a photovoltaic performance tester under AM 1.5G standard simulated sunlight. The results show that the device's... PCE It was 19.87%. V oc It is 1.19V. J sc 20.81 mA / cm 2 , FF It is 80.22%.

[0081] Application Example 4 The preparation method is the same as in Application Example 1, except that the amount of HEMFA added to the precursor solution is 10% of the molar amount of PbI2.

[0082] Performance Testing: The device was tested using a photovoltaic performance tester under AM 1.5G standard simulated sunlight. The results show that the device… PCE It is 19.19%. V oc It is 1.18V. J sc21.72 mA / cm 2 , FF It is 75.01%.

[0083] Application Example 5 The preparation method is the same as in Application Example 1, except that the amount of HEMFA added to the precursor solution is 15% of the molar amount of PbI2.

[0084] Performance Testing: The device was tested using a photovoltaic performance tester under AM 1.5G standard simulated sunlight. The results show that the device… PCE It is 17.73%. V oc It is 1.14V. J sc 21.72 mA / cm 2 , FF It is 71.37%.

[0085] Application Comparative Example 1 The preparation method is the same as in Application Example 1, except that no HEMFA is added to the precursor solution, and pure DMF is used as the solvent.

[0086] Performance Testing: The device was tested using a photovoltaic performance tester under AM 1.5G standard simulated sunlight. The results show that the device… PCE It is 17.52%. V oc It is 1.147V. J sc 20.45 mA / cm 2 , FF It is 74.7%.

[0087] It should be noted that when numerical ranges are involved in this invention, it should be understood that the two endpoints of each numerical range, as well as any value between the two endpoints, can be selected. Since the steps and methods used are the same as in the embodiments, preferred embodiments are described in this invention to avoid redundancy. Although preferred embodiments of this invention have been described, those skilled in the art, once they understand the basic inventive concept, can make other changes and modifications to these embodiments, and all such changes and modifications fall within the scope of this invention.

[0088] Obviously, those skilled in the art can make various modifications and variations to this invention without departing from its spirit and scope. If these modifications and variations fall within the scope of equivalents of this invention, then this invention also intends to include these modifications and variations.

[0089] To verify the comprehensive advantages of the embodiment of the present invention (HEMFA control system) compared with the traditional pure DMF system (Comparative Example 1) in terms of film morphology, crystal orientation, phase distribution, and device performance, a series of characterization tests were carried out on the above-mentioned films and corresponding devices. The specific results are as follows: Test 1: use 1 ¹H NMR was used to characterize the molecular structure of the regulator, its coordination with metal ions, and its binding ability with organic cations, revealing the crystallization regulation mechanism of HEMFA at the molecular level. The results are as follows: Figure 1 As shown.

[0090] Figure 1 Comparison of ¹H NMR spectra of pure DMF, pure HEMFA, and DMF-PbI2, HEMFA-PbI2, DMF-BAI, HEMFA-BAI, DMF-MAI, and HEMFA-MAI. Specifically, (a) shows the ¹H NMR spectra of pure DMF and DMF-PbI2; (b) shows the ¹H NMR spectra of pure HEMFA and HEMFA-PbI2; (c) shows the ¹H NMR spectra of DMF-BAI and HEMFA-BAI; and (d) shows the ¹H NMR spectra of DMF-MAI and HEMFA-MAI.

[0091] like Figure 1 In (a), a comparison of the proton NMR spectra of pure DMF and the DMF-PbI2 system. The formyl (-CHO) proton chemical shift of pure DMF is 7.943 ppm, which only shifts slightly to 7.955 ppm after the addition of an equimolar amount of PbI2. The N-methyl characteristic peak also shows no significant shift change.

[0092] like Figure 1 (b) Comparison of 1H NMR spectra of pure HEMFA and the HEMFA-PbI2 system. The proton chemical shifts of the formyl group (-CHO), hydroxyl group (-OH), and β-methylene group (-CH2-) in pure HEMFA are 7.976 ppm, 4.427 ppm, and 3.638 ppm, respectively. After adding an equimolar amount of PbI2, all three characteristic peaks shifted towards the lower field, with corresponding shifts of 7.989 ppm, 4.459 ppm, and 3.651 ppm, respectively, with the hydroxyl proton shift being the most significant. This result confirms that HEMFA can form a two-site synergistic chelation effect with the amide carbonyl group and the side-chain hydroxyl group, thereby enhancing the thermodynamic stability of Pb through the chelation effect. 2+ Its coordination ability is significantly better than that of traditional DMF solvents.

[0093] comprehensive Figure 1 The results in (c) and (d) show that HEMFA exhibits differentiated binding abilities for organic cations of different sizes: for small-sized MA...+ The hydrogen bonding effect is significantly enhanced for large-size BA + The binding effect is relatively weakened, achieving a reversal of cation binding capacity. This selective binding effect can effectively delay MA in the early stages of crystallization. + The disordered and rapid precipitation of perovskite can regulate the phase evolution dynamics of quasi-two-dimensional perovskite, thereby optimizing the phase distribution and crystallization quality of the film from the root.

[0094] Test 2: In-situ heated optical microscopes were used to observe the crystallization behavior of the precursor solutions of the examples and comparative examples during the heating process in real time, and to intuitively analyze the regulatory effect of the regulator on the crystallization process.

[0095] like Figure 2 As shown in Figure (a), the precursor droplets of Comparative Example 1 (pure DMF system) have a short crystallization induction time after being heated, and burst nucleation occurs in about 180s. A large number of disordered and coarse through-type needle-like mesophases (MA2Pb3I3-2DMF) are precipitated in a short time; the final film has a rough morphology and disordered phase distribution.

[0096] like Figure 2 As shown in Figure (b), in Example 1 (1% HEMFA system), the crystallization induction time was extended to about 240s, and the crystallization rate slowed down. There were still many needle-like mesophases in the film, but their number and size were significantly reduced compared to the pure DM system, and the phase uniformity of the film was improved to a certain extent.

[0097] like Figure 2 As shown in (c), in Example 2 (3% HEMFA system), the crystallization induction time was further extended to about 290s, with only a very small amount of short needle-like intermediate phase; the crystallization front was generally smoother, the uniformity of advancement was significantly improved, and the degree of synchronous grain growth was enhanced; the uniformity of the thin film phase was slightly enhanced, and the vertical orientation trend began to appear.

[0098] like Figure 2 As shown in (d), the crystallization induction time of Example 3 (5% HEMFA system, optimal addition amount) is moderate, and stable crystallization begins at about 350s, with the best crystallization kinetic control effect; no needle-like mesophase precipitation occurs throughout the process, and there is no explosive nucleation phenomenon; the grains nucleate synchronously and grow synergistically, ultimately forming a dense, flat film morphology with a highly uniform phase distribution.

[0099] like Figure 2 As shown in (e), the crystallization induction time of Example 4 (10% HEMFA system) was significantly extended to about 420s, and the overall crystallization rate slowed down; no needle-like mesophase was generated throughout the process, and the crystallization front remained smooth overall; slight asynchrony of grain growth occurred, grain size differentiation occurred, and the morphological uniformity of local areas decreased slightly.

[0100] like Figure 2 As shown in (f), the crystallization induction time of Example 5 (15% HEMFA system) was significantly extended to about 470s, and the crystallization driving force was significantly insufficient; no needle-like mesophase precipitated throughout the process, but the grain morphology was irregular and island-like phenomena appeared locally; the final film density decreased and the phase uniformity was further reduced.

[0101] Test 3: The surface morphology and cross-sectional structure of quasi-two-dimensional perovskite thin films were observed using scanning electron microscopy, and the film compactness and grain orientation characteristics were analyzed.

[0102] like Figure 3 As shown in Figure (a), in Comparative Example 1 (pure DMF system), the SEM image of the film surface shows a disordered needle-like phase with irregular grain boundary contours and obvious micropores; the cross-sectional SEM image further confirms that the needle-like phase is randomly distributed and partially penetrates the entire film thickness, easily forming through-type leakage paths, and the overall film density is poor.

[0103] like Figure 3 As shown in Figure (b), in Example 3 (5% HEMFA system), the surface smoothness of the film was greatly improved, the needle-like phase was completely eliminated, the grain size was uniform, and a highly dense continuous film without obvious pores was formed. The cross-sectional SEM image clearly shows that the perovskite grains exhibit excellent orientation growth characteristics perpendicular to the substrate, and the grains are regularly stacked from top to bottom, forming a smooth longitudinal charge transport channel.

[0104] Test 4: X-ray diffraction was used to qualitatively characterize the crystal structure, phase composition and crystallinity of the thin film, and the effect of HEMFA on phase purity was analyzed.

[0105] like Figure 4 As shown in Figure (a), obvious diffraction peaks of the low-n-value phase (n≤2) can be detected in the pure DMF system of Comparative Example 1, while characteristic signals of the 3D perovskite impurity phase are also present, indicating low phase purity and severe phase segregation. In contrast, in the thin film of Example 3 regulated by 5% HEMFA, the diffraction signals of the low-n-value phase and the 3D impurity phase are significantly suppressed, and the intensity of the characteristic diffraction peaks corresponding to the target standard two-dimensional perovskite phase is greatly improved, with sharp peak shapes, indicating that the long-range order of the crystal is significantly enhanced and the phase purity is effectively improved.

[0106] Test 5: The phase distribution and phase purity of thin films are characterized using ultraviolet-visible absorption spectroscopy (UV-Vis), such as... Figure 4As shown in Figure (b), the absorption spectrum of the pure DMF film in Comparative Example 1 contains multiple exciton characteristic absorption peaks corresponding to the low n-value phases (n=2, 3), indicating severe phase segregation and a high proportion of low-dimensional phases within the film. In contrast, the absorption spectrum of the film in Example 3, regulated by 5% HEMFA, is dominated by the absorption of the high n-value phase (n≥3), and the exciton peaks of the low-dimensional phases are greatly weakened, proving that a highly uniform quantum well distribution has been formed within the system, and the phase uniformity has been significantly improved.

[0107] Test 6: Grazing incidence X-ray wide-angle scattering (GIWAXS) technology was used to quantitatively test the crystal orientation and spatial phase distribution of thin films, providing a direct characterization of the vertical orientation and phase purity of the films.

[0108] like Figure 5 As shown in Figure (a), in Comparative Example 1 (pure DMF system), the two-dimensional GIWAXS pattern exhibits diffuse Debye-Sherlock rings, and the low scattering vector (q-value) region shows obvious low-n-value impurity phase scattering signals, indicating that the thin film crystals are randomly oriented and exhibit severe vertical phase segregation. Figure 5 As shown in (b), in Example 3 (5% HEMF system), the spectrum is in the direction perpendicular to the substrate (q). z The crystal exhibits sharp, discrete, and strong Bragg diffraction spots along the axis, with no obvious impurity scattering signals in the low q region, indicating that the crystal has a highly preferential vertical orientation and high phase purity with uniform phase distribution.

[0109] Test 7: Photoluminescence scanning imaging (PL mapping) technology was used to visualize the spatial distribution of the luminescence properties of thin films, and to evaluate the uniformity of phase and defect distribution within the films. PL mapping images are used to characterize the spatial uniformity of the luminescence properties of thin films, indirectly reflecting the uniformity of phase distribution.

[0110] like Figure 6 As shown in Figure (a), the PL mapping image of Comparative Example 1 (pure DMF system) exhibits significant differences in brightness and darkness contrast, and uneven distribution of luminescence intensity and peak positions, indicating the presence of significant defect aggregation and phase separation regions within the film, resulting in poor uniformity. Figure 6 As shown in Figure (b), in Example 3 (5% HEMFA system), the luminescence intensity and peak hue in the scanning area are highly consistent, and the image is in a uniform monochromatic tiling state with no obvious difference in brightness; this proves that the HEMFA regulation strategy can effectively guide the precursor to nucleate and grow in an orderly manner throughout the entire film, significantly solving the problem of uneven phase distribution, and providing a morphological and uniform basis for the device to achieve efficient and stable high voltage output.

[0111] Test 8: The EL performance and electroluminescence external quantum efficiency (EQE) of the assembled perovskite solar cell device were evaluated. EL Tests were conducted to analyze the degree of nonradiative recombination and energy loss within the device.

[0112] like Figure 7 As shown in Figure (a), the EQE of the device using Comparative Example 1 (pure DMF system) is... EL The extremely low values ​​and weak luminescence intensity under the same bias voltage indicate that a large number of injected charge carriers undergo nonradiative recombination through internal defects, resulting in severe energy loss. Figure 7 In (b), the EQE of the device using Example 3 (5% HEMFA system) EL The results show a significant improvement, with stronger luminescence at the same low bias voltage, demonstrating a substantial reduction in the internal defect density of the thin film, effective suppression of nonradiative recombination, and a significant reduction in device energy loss.

[0113] Test 9: Simulated sunlight under AM 1.5G standard (100mW / cm²) 2 Under these conditions, the photovoltaic performance of the device was tested to verify the overall improvement effect of HEMFA regulation on the device's photoelectric performance.

[0114] like Figure 8 As shown, the device using Comparative Example 1 (pure DMF system) suffers from severe internal phase segregation, needle-like phase defects, and leakage current channels, resulting in a low open-circuit voltage ( ). V oc The open-circuit voltage is only 1.12V, resulting in significant energy loss and low overall photoelectric conversion efficiency. However, the device using Example 3 (5% HEMFA system) benefits from high phase uniformity, high vertical orientation, and low defect density, effectively suppressing non-radiative recombination and leakage current, and reducing the open-circuit voltage (…). V oc The voltage was increased to 1.2V, and the short-circuit current density was ( J sc ) and fill factor ( FF All of these aspects have been significantly improved, resulting in a substantial increase in overall photoelectric conversion efficiency.

[0115] The above are merely preferred embodiments of the present invention and are not intended to limit the present invention. Any modifications, equivalent substitutions, and improvements made within the spirit and principles of the present invention should be included within the protection scope of the present invention.

Claims

1. A method for preparing an RP phase- aligned two-dimensional perovskite thin film, characterized in that, Includes the following steps: A quasi-two-dimensional perovskite precursor, methylamine chloride, and N-(2-hydroxyethyl)-N-methylformamide were dissolved in N,N-dimethylformamide to obtain a precursor solution; the precursor solution was coated on a substrate and annealed to obtain a vertically oriented RP phase quasi-two-dimensional perovskite film. The amount of N-(2-hydroxyethyl)-N-methylformamide added is 0.5% to 20% of the molar amount of lead source in the quasi-two-dimensional perovskite precursor.

2. The method of claim 1, wherein the RP perovskite thin film is a two-dimensional perovskite thin film. The amount of N-(2-hydroxyethyl)-N-methylformamide added is 2% to 10% of the molar amount of lead source in the quasi-two-dimensional perovskite precursor.

3. The method of claim 2, wherein the RP perovskite thin film is a two-dimensional perovskite thin film. The amount of N-(2-hydroxyethyl)-N-methylformamide added is 5% of the molar amount of lead source in the quasi-two-dimensional perovskite precursor.

4. The method for preparing RP-phase quasi-two-dimensional perovskite thin films according to claim 1, characterized in that, The amount of methylammonium chloride added is 12% to 15% of the molar amount of lead source in the quasi-two-dimensional perovskite precursor.

5. The method for preparing RP-phase quasi-two-dimensional perovskite thin films according to claim 1, characterized in that, The quasi-two-dimensional perovskite precursor is obtained by mixing lead source, butylammonium ion source and methylammonium ion source; the molar ratio of lead source, butylammonium ion source and methylammonium ion source is n:2:n-1; n is an integer.

6. The method for preparing RP-phase quasi-two-dimensional perovskite thin films according to claim 1, characterized in that, The preheating temperature of the substrate is 60℃~70℃.

7. The method for preparing RP-phase quasi-two-dimensional perovskite thin films according to claim 1, characterized in that, The annealing temperature is 100℃~110℃, and the annealing time is 10min~15min.

8. A two-dimensional perovskite thin film with RP phase, characterized in that, The RP-phase quasi-two-dimensional perovskite thin film was prepared by any one of claims 1 to 7.

9. The RP-phase quasi-two-dimensional perovskite thin film according to claim 8, characterized in that, The RP phase quasi-two-dimensional perovskite thin film is formed by using N-(2-hydroxyethyl)-N-methyl formamide as a crystallization regulator, using the crystallization regulator to regulate the Pb 2+ A bidentate chelate complex is formed to induce the inorganic perovskite lattice to grow in an orderly and stacked manner from top to bottom in a direction perpendicular to the substrate together with the organic cation in the quasi-two-dimensional perovskite precursor, thereby forming a vertically oriented RP phase quasi-two-dimensional perovskite thin film. The inorganic perovskite lattice is PbI6 4- Octahedra are interconnected by sharing corners to form inorganic framework layers; the organic cations are butylammonium ions and methylammonium ions.

10. A perovskite solar cell, characterized in that, Including the RP phase quasi-two-dimensional perovskite thin film as described in claim 8.